Indaptus Therapeutics is trading 6.45% down in after-hours trading at $1.73, with no confirmed company-specific announcement or late-breaking catalyst identified.
- It closed September 8, 2026 at $1.85 after a 51.64% regular-session surge.
- Available coverage points instead to the September 4 routine board-member resignation.
- The broader market finished risk-off: the S&P 500 fell 0.55% and the Dow 1.06%; the move appears primarily driven by post-rally volatility or profit-taking. Confidence remains low.